1201 Noema ECP EMB 1201 2am ET
BioCentury & Getty Images

Emerging Company Profile

Sofinnova’s Papiernik, Costa and Roche alum Garibaldi carve orphan neurology play Noema out of the pharma’s assets

Emerging Company Profile: Noema emerges from stealth with $59M to develop four clinical neurology programs in-licensed from Roche

Noema has emerged from stealth with $59M in a series A led by Sofinnova Partners and Polaris to develop four clinical neurology programs in-licensed from Roche. 

Dec 2, 2020 | 2:08 AM GMT

Five years after Sofinnova Partners’ Antoine Papiernik first connected with Roche neurology veteran George Garibaldi, the

Read the full 881 word article

How to gain access

Continue reading with a
two-week free trial.